LDH-A Acetylation: Implication in Cancer
LDH-A Acetylation: Implication in Cancer |
https://doi.org/10.18632/oncotarget.1007
Di Zhao,
Yue Xiong,
Qun-Ying Lei,
and Kun-Liang Guan
|
802-803 |
Phenylbutyrate increases activity of pyruvate dehydrogenase complex.
Phenylbutyrate increases activity of pyruvate dehydrogenase complex. |
https://doi.org/10.18632/oncotarget.1000
Rosa Ferriero,
and Nicola Brunetti-Pierri
|
804-805 |
Necdin, a p53 target gene, in stem cells
Necdin, a p53 target gene, in stem cells |
https://doi.org/10.18632/oncotarget.997
Takashi Asai,
Yan Liu,
and Stephen D Nimer
|
806-807 |
STAT5b in LGL leukemia – a novel therapeutic target?
STAT5b in LGL leukemia – a novel therapeutic target? |
https://doi.org/10.18632/oncotarget.1035
Hanna L. M. Rajala,
and Satu Mustjoki
|
808-809 |
Mouse model resembling human lung cancer
Mouse model resembling human lung cancer |
https://doi.org/10.18632/oncotarget.1017
Zuoxiang Xiao,
Qun Jiang,
Jami Willette-Brown,
and Yinling Hu
|
810-811 |
Single circulating tumor cell sequencing for monitoring
Single circulating tumor cell sequencing for monitoring |
https://doi.org/10.18632/oncotarget.1026
Martina Auer,
Ellen Heitzer,
Peter Ulz,
Jochen B. Geigl,
and Michael R Speicher
|
812-813 |
Germline Counterparts of Oncogenic Mutations: Who Gives a JAK?
Germline Counterparts of Oncogenic Mutations: Who Gives a JAK? |
https://doi.org/10.18632/oncotarget.1105
Adam J Mead,
Stefan N Constantinescu,
and Sten Eirik W Jacobsen
|
814-815 |
Targeting HSF1 sensitizes cancer cells to HSP90 inhibition
Targeting HSF1 sensitizes cancer cells to HSP90 inhibition |
https://doi.org/10.18632/oncotarget.991
Yaoyu Chen,
Jinyun Chen,
Alice Loo,
Savina Jaeger,
Linda Bagdasarian,
Jianjun Yu,
Franklin Chung,
Joshua Korn,
David Ruddy,
Ribo Guo,
Margaret Mclaughlin,
Fei Feng,
Ping Zhu,
Frank Stegmeier,
Raymond Pagliarini,
Dale Porter,
and Wenlai Zhou
|
816-829 |
Pharmacologic targeting of the PI3K/mTOR pathway controls release of angioregulators from primary human acute myeloid leukemia cells and their neighboring stromal cells
Pharmacologic targeting of the PI3K/mTOR pathway controls release of angioregulators from primary human acute myeloid leukemia cells and their neighboring stromal cells |
https://doi.org/10.18632/oncotarget.971
Håkon Reikvam,
Ina Nepstad,
Øystein Bruserud,
and Kimberley Joanne Hatfield
|
830-843 |
Cross-species genomic and epigenomic landscape of retinoblastoma
Cross-species genomic and epigenomic landscape of retinoblastoma |
https://doi.org/10.18632/oncotarget.1051
Claudia A. Benavente,
Justina D. McEvoy,
David Finkelstein,
Lei Wei,
Guolian Kang,
Yong-Dong Wang,
Geoffrey Neale,
Susan Ragsdale,
Virginia Valentine,
Armita Bahrami,
Jamshid Temirov,
Stanley Pounds,
Jinghui Zhang,
and Michael A. Dyer
|
844-859 |
Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia
Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia |
https://doi.org/10.18632/oncotarget.1018
Yin Tong,
Liangshun You,
Hui Liu,
Lu Li,
Haitao Meng,
Qijun Qian,
and Wenbin Qian
|
860-874 |
pRb controls Estrogen Receptor alpha protein stability and activity
pRb controls Estrogen Receptor alpha protein stability and activity |
https://doi.org/10.18632/oncotarget.1036
Isabella Caligiuri,
Giuseppe Toffoli,
Antonio Giordano,
and Flavio Rizzolio
|
875-883 |
Germline PTPRD Mutations in Ewing Sarcoma: Biologic and Clinical Implications
Germline PTPRD Mutations in Ewing Sarcoma: Biologic and Clinical Implications |
https://doi.org/10.18632/oncotarget.1021
Yunyun Jiang,
Filip Janku,
Vivek Subbiah,
Laura S. Angelo,
Aung Naing,
Peter M. Anderson,
Cynthia E. Herzog,
Siqing Fu,
Robert S. Benjamin,
and Razelle Kurzrock
|
884-889 |
Thymoma Patients Treated in a Phase I Clinic at MD Anderson Cancer Center: Responses to mTOR Inhibitors and Molecular Analyses
Thymoma Patients Treated in a Phase I Clinic at MD Anderson Cancer Center: Responses to mTOR Inhibitors and Molecular Analyses |
https://doi.org/10.18632/oncotarget.1015
Jennifer J. Wheler,
David Hong,
Stephen G. Swisher,
Gerald S. Falchook,
Apostolia Maria Tsimberidou,
Thorunn Helgason,
Aung Naing,
Bettzy Stephen,
Filip Janku,
Philip J. Stephens,
Roman Yelensky,
and Razelle Kurzrock
|
890-898 |
Myeloablative Anti-CD20 Radioimmunotherapy +/- High-Dose Chemotherapy Followed by Autologous Stem Cell Support for Relapsed/Refractory B-Cell Lymphoma Results in Excellent Long-Term Survival
Myeloablative Anti-CD20 Radioimmunotherapy +/- High-Dose Chemotherapy Followed by Autologous Stem Cell Support for Relapsed/Refractory B-Cell Lymphoma Results in Excellent Long-Term Survival |
https://doi.org/10.18632/oncotarget.1037
Julia Y. Wagner,
Kathleen Schwarz,
Susanne Schreiber,
Burkhard Schmidt,
Hans-Jürgen Wester,
Markus Schwaiger,
Christian Peschel,
Christoph von Schilling,
Klemens Scheidhauer,
and Ulrich Keller
|
899-910 |
Antiestrogen-binding site ligands induce autophagy in myeloma cells that proceeds through alteration of cholesterol metabolism
Antiestrogen-binding site ligands induce autophagy in myeloma cells that proceeds through alteration of cholesterol metabolism |
https://doi.org/10.18632/oncotarget.1066
Brigitte Sola,
Marc Poirot,
Philippe de Medina,
Sophie Bustany,
Véronique Marsaud,
Sandrine Sivente-Poirot,
and Jack-Michel Renoir
|
911-922 |
Acetylation of the Cell-Fate Factor Dachshund Determines p53 Binding and Signaling Modules in Breast Cancer
Acetylation of the Cell-Fate Factor Dachshund Determines p53 Binding and Signaling Modules in Breast Cancer |
https://doi.org/10.18632/oncotarget.1094
Ke Chen,
Kongming Wu,
Michael Gormley,
Adam Ertel,
Wei Zhang,
Jie Zhou,
Gabriele DiSante,
Zhiping Li,
Hallgeir Rui,
Andrew A. Quong,
Steven B. McMahon,
Haiteng Deng,
Michael P. Lisanti,
Chenguang Wang,
and Richard G. Pestell
|
923-935 |
Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5
Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5 |
https://doi.org/10.18632/oncotarget.1108
Huabo Wang,
Jay Chauhan,
Angela Hu,
Kelsey Pendleton,
Jeremy L. Yap,
Philip E. Sabato,
Jace W. Jones,
Mariarita Perri,
Jianshi Yu,
Erika Cione,
Maureen A. Kane,
Steven Fletcher,
and Edward V. Prochownik
|
936-949 |